Placental oxidative stress and maternal endothelial function in pregnant women with normotensive fetal growth restriction

J Matern Fetal Neonatal Med. 2018 Apr;31(8):1051-1057. doi: 10.1080/14767058.2017.1306510. Epub 2017 Apr 3.

Abstract

Objective: The purpose of this study was to investigate the relationship between placental oxidative stress and maternal endothelial function in pregnant women with normotensive fetal growth restriction (FGR).

Methods: We examined serum concentrations of oxygen free radicals (d-ROMs), maternal angiogenic factor (PlGF), and sFlt-1, placental oxidative DNA damage, and maternal endothelial function in 17 women with early-onset preeclampsia (PE), 18 with late-onset PE, 14 with normotensive FGR, and 21 controls. Flow-mediated vasodilation (FMD) was assessed as a marker of maternal endothelial function. Immunohistochemical analysis was performed to measure the proportion of placental trophoblast cell nuclei staining positive for 8-hydroxy-2'-deoxyguanosine (8-OHdG), a marker of oxidative DNA damage.

Results: Maternal serum d-ROM, sFlt-1 concentrations, and FMD did not significantly differ between the control and normotensive FGR groups. The proportion of nuclei staining positive for 8-OHdG was significantly higher in the normotensive FGR group relative to the control group.

Conclusions: Our findings demonstrate that, despite the presence of placental oxidative DNA damage as observed in PE patients, pregnant women with normotensive FGR show no increase in the concentrations of sFlt-1 and d-ROMs, or a decrease in FMD.

Keywords: PlGF; Preeclampsia; endothelial dysfunction; normotensive FGR; oxidative stress; sFlt-1.

MeSH terms

  • Adult
  • Case-Control Studies
  • DNA Damage
  • Endothelium, Vascular / physiopathology*
  • Female
  • Fetal Growth Retardation / blood*
  • Fetal Growth Retardation / physiopathology
  • Humans
  • Oxidative Stress*
  • Placenta / metabolism*
  • Placenta Growth Factor / blood
  • Pregnancy
  • Vascular Endothelial Growth Factor Receptor-1 / blood

Substances

  • Placenta Growth Factor
  • FLT1 protein, human
  • Vascular Endothelial Growth Factor Receptor-1